Jafron Biomedical gains approval for new medical device
Jafron Biomedical (SZSE:300529) announced it has received a medical device registration certificate from the Guangdong Provincial Drug Administration for its new product: a disposable waste fluid bag, effective May 27, 2025. Classified as a Class II medical device, the bag functions as a waste fluid collection device during hemodialysis and hemofiltration treatments. The registration is valid for five years, expiring on May 26, 2030. Jafron believes that integration of the bag with its existing equipment and tubing will strengthen its position in the blood purification field.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Jafron Biomedical publishes news
Free account required • Unsubscribe anytime